FDA Perspective on New Therapies for Amyloidosis

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

FDA Perspective on New Therapies for Amyloidosis

By Houston Methodist FEATURING Rosalyn Adigun

187 views

April 14, 2023

Houston Methodist’s mission is to provide high-quality, cost-effective health care that delivers the best value to the people we serve in a spiritual environment of caring in association with internationally recognized teaching and research.
For a full listing of current courses with accredited educational opportunities, visit learn.houstonmethodist.org
To access our library of previously recorded activities, visit watch.houstonmethodist.org
Please direct all further inquiries here

Comments 0